Julio Ramírez

Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial

Frances Humby, Patrick Durez, Maya H Buch et al. · The Lancet · 2021 · 315 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial

Felice Rivellese, Anna E. A. Surace, Katriona Goldmann et al. · Nature Medicine · 2022 · 279 citations · Full text

Life Sciences, Immunology, Internal Medicine +17

Anti-carbamylated proteins antibody repertoire in rheumatoid arthritis: evidence of a new autoantibody linked to interstitial lung disease

Raúl Castellanos‐Moreira, S. C. Rodriguez-García, María J. Gómara et al. · Annals of the Rheumatic Diseases · 2020 · 86 citations

Life Sciences, Immunology, Internal Medicine +17

Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis

Adrià Aterido, Juan D. Cañete, Jesús Tornero et al. · Annals of the Rheumatic Diseases · 2018 · 78 citations

Life Sciences, Genetics, Molecular Genetics +15

Synovial cytokine expression in psoriatic arthritis and associations with lymphoid neogenesis and clinical features

Raquel Celis, Núria Planell, J.L. Fernández-Sueiro et al. · Arthritis Research & Therapy · 2012 · 76 citations · Full text

Medicine, Immunology, Pathology +17